{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T01:45:42Z","timestamp":1778291142016,"version":"3.51.4"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"36","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1097\/md.0000000000012270","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T09:22:20Z","timestamp":1536225740000},"page":"e12270","source":"Crossref","is-referenced-by-count":17,"title":["The efficacy of oral versus intravenous tranexamic acid in reducing blood loss after primary total knee and hip arthroplasty"],"prefix":"10.1097","volume":"97","author":[{"given":"Fei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun-Chi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Xu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-109-20210826","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0968-0160(00)00047-8","article-title":"How much blood is really lost in total knee arthroplasty?. Correct blood loss management should take hidden loss into account","volume":"7","author":"Sehat","year":"2000","journal-title":"Knee"},{"key":"R2-109-20210826","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.arth.2013.03.035","article-title":"Transfusion rates are increasing following total hip arthroplasty: risk factors and outcomes","volume":"28","author":"Browne","year":"2013","journal-title":"J Arthroplasty"},{"key":"R3-109-20210826","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.arth.2014.08.020","article-title":"Does tranexamic acid reduce blood transfusion cost for primary total hip arthroplasty? A case-control study","volume":"30","author":"Harris","year":"2015","journal-title":"J Arthroplasty"},{"key":"R4-109-20210826","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2106\/00004623-199901000-00002","article-title":"An analysis of blood management in patients having a total hip or knee arthroplasty","volume":"81","author":"Bierbaum","year":"1999","journal-title":"J Bone Joint Surg Am"},{"key":"R5-109-20210826","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0049-3848(97)00004-2","article-title":"The effect of tranexamic acid on local and plasma fibrinolysis during total knee arthroplasty","volume":"85","author":"Benoni","year":"1997","journal-title":"Thromb Res"},{"key":"R6-109-20210826","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.aott.2016.06.007","article-title":"Efficacy of preoperative administration of single high dose intravenous tranexamic acid in reducing blood loss in total knee arthroplasty: a prospective clinical study","volume":"50","author":"Akgul","year":"2016","journal-title":"Acta Orthop Traumatol Turc"},{"key":"R7-109-20210826","doi-asserted-by":"crossref","first-page":"g4829","DOI":"10.1136\/bmj.g4829","article-title":"Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety","volume":"349","author":"Poeran","year":"2014","journal-title":"BMJ"},{"key":"R8-109-20210826","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5792\/ksrr.16.074","article-title":"Blood sparing efficacy of oral tranexamic acid in primary total knee arthroplasty: a randomized controlled trial","volume":"29","author":"Lee","year":"2017","journal-title":"Knee Surg Relat Res"},{"key":"R9-109-20210826","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1046\/j.1445-2197.2003.02762.x","article-title":"Methodological index for non-randomized studies","volume":"73","author":"Dent","year":"2003","journal-title":"ANZ J Surg"},{"key":"R10-109-20210826","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1213\/01.ANE.0000136770.75805.19","article-title":"The postoperative blood-sparing efficacy of oral versus intravenous tranexamic acid after total knee replacement","volume":"99","author":"Zohar","year":"2004","journal-title":"Anesth Analg"},{"key":"R11-109-20210826","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2106\/JBJS.16.00188","article-title":"Oral and intravenous tranexamic acid are equivalent at reducing blood loss following total hip arthroplasty: a randomized controlled trial","volume":"99","author":"Kayupov","year":"2017","journal-title":"J Bone Joint Surg Am"},{"key":"R12-109-20210826","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.arth.2016.02.081","article-title":"Rand Young Investigator's Award: a randomized controlled trial of oral and intravenous tranexamic acid in total knee arthroplasty: the same efficacy at lower cost?","volume":"31","author":"Fillingham","year":"2016","journal-title":"J Arthroplasty"},{"key":"R13-109-20210826","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.arth.2017.09.062","article-title":"Oral vs intravenous vs topical tranexamic acid in primary hip arthroplasty: a prospective, randomized, double-blind, controlled study","volume":"33","author":"Luo","year":"2018","journal-title":"J Arthroplasty"},{"key":"R14-109-20210826","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1302\/0301-620X.95B11.31055","article-title":"Oral versus intravenous tranexamic acid in enhanced-recovery primary total hip and knee replacement: results of 3000 procedures","volume":"95-B","author":"Irwin","year":"2013","journal-title":"Bone Joint J"},{"key":"R15-109-20210826","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1177\/1060028017735859","article-title":"Comparison of oral and intravenous tranexamic acid for prevention of perioperative blood loss in total knee and total hip arthroplasty","volume":"52","author":"Gortemoller","year":"2017","journal-title":"Ann Pharmacother"},{"key":"R16-109-20210826","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1177\/1933719115623646","article-title":"Efficacy of tranexamic acid on myomectomy-associated blood loss in patients with multiple myomas: a randomized controlled clinical trial","volume":"23","author":"Shaaban","year":"2016","journal-title":"Reproduct Sci"},{"key":"R17-109-20210826","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1007\/s12630-016-0684-0","article-title":"Dual-route tranexamic acid to reduce blood loss in coronary artery bypass graft surgery: a randomized controlled trial","volume":"63","author":"Prokopchuk-Gauk","year":"2016","journal-title":"Can J Anaesth"},{"key":"R18-109-20210826","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1097\/TP.0b013e31821ab9f8","article-title":"Aprotinin versus tranexamic acid during liver transplantation: impact on blood product requirements and survival","volume":"91","author":"Massicotte","year":"2011","journal-title":"Transplantation"},{"key":"R19-109-20210826","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/rheumatology\/37.1.34","article-title":"Tranexamic acid, an inhibitor of plasminogen activation, reduces urinary collagen cross-link excretion in both experimental and rheumatoid arthritis","volume":"37","author":"Ronday","year":"1998","journal-title":"Br J Rheumatol"},{"key":"R20-109-20210826","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.arth.2013.06.011","article-title":"Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty","volume":"28","author":"Konig","year":"2013","journal-title":"J Arthroplasty"},{"key":"R21-109-20210826","first-page":"67","article-title":"Use of intravenous tranexamic acid in total knee arthroplasty: a meta-analysis of randomized controlled trials","volume":"16","author":"Fu","year":"2013","journal-title":"Chin J Traumatol"},{"key":"R22-109-20210826","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.arth.2016.06.058","article-title":"Blood-sparing efficacy of oral tranexamic acid in primary total hip arthroplasty","volume":"32","author":"Lee","year":"2017","journal-title":"J Arthroplasty"},{"key":"R23-109-20210826","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1034\/j.1399-6576.2002.461007.x","article-title":"Tranexamic acid given intraoperatively reduces blood loss after total knee replacement: a randomized, controlled study","volume":"46","author":"Veien","year":"2002","journal-title":"Acta Anaesthesiol Scand"},{"key":"R24-109-20210826","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/bja\/74.5.534","article-title":"Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with total knee arthroplasty","volume":"74","author":"Hiippala","year":"1995","journal-title":"Br J Anaesth"},{"key":"R25-109-20210826","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/bja\/ael057","article-title":"Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial","volume":"96","author":"Camarasa","year":"2006","journal-title":"Br J Anaesth"},{"key":"R26-109-20210826","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1302\/0301-620X.78B3.0780434","article-title":"Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients","volume":"78","author":"Benoni","year":"1996","journal-title":"J Bone Joint Surg Br"},{"key":"R27-109-20210826","doi-asserted-by":"crossref","first-page":"188","DOI":"10.5792\/ksrr.2016.28.3.188","article-title":"Effect of tranexamic acid on blood loss and blood transfusion reduction after total knee arthroplasty","volume":"28","author":"Seol","year":"2016","journal-title":"Knee Surg Relat Res"},{"key":"R28-109-20210826","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13018-014-0090-7","article-title":"The efficacy of a thrombin-based hemostatic agent in primary total knee arthroplasty: a meta-analysis","volume":"9","author":"Wang","year":"2014","journal-title":"J Orthop Surg Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201809070-00109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T14:31:18Z","timestamp":1629988278000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201809070-00109"}},"subtitle":["A meta-analysis"],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":28,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000012270","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}